Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279200 · ClinicalTrials.gov registry record · Phase 4
Use of High Cost Monitoring During Letrozole Ovulation Induction
A Phase 4 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT01279200 is a Phase 4 study that has completed, run by University of Michigan. The registered enrollment target is 21 participants.
The verdict
NCT01279200, a Phase 4 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate monitoring methods during ovulation induction cycles with letrozole and their effect on pregnancy rates. Monitoring ovulation induction cycles with letrozole can be done with a variety of methods, the two most commonly utilized are home-based urinary LH kits (or ovulation predictor kits) and office-based midcycle follicular ultrasound. Letrozole coupled with follicular monitoring by ultrasound may add extra cost per cycle with no improvement in fecundability (pregnancy rates per cycle).
Interventions
- OTHER Midcycle ultrasound + hCG injection
- OTHER Urinary LH kits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01279200
The ClinicalTrials.gov registry entry for NCT01279200 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midcycle ultrasound + hCG injection is the first listed.
NCT01279200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01279200 about?
NCT01279200 is a clinical study titled "Use of High Cost Monitoring During Letrozole Ovulation Induction". The purpose of this study is to investigate monitoring methods during ovulation induction cycles with letrozole and their effect on pregnancy rates. Monitoring ovulation induction cycles with letrozole can be done with a variety of methods, the two most commonly utilized are home-based urinary LH ki...
What is the current status of trial NCT01279200?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2011-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01279200?
The interventions under investigation include: Midcycle ultrasound + hCG injection (OTHER), Urinary LH kits (OTHER).
Who is sponsoring clinical trial NCT01279200?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.